Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 2: Emerging Molecular Targets (Educational Session)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Introduction
Chairperson: Matthew V. Lorenzi, Ph.D.
Bristol-Myers Squibb Company, Princeton, NJ
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Discovery of small molecule sirtuin inhibitors through a p53 activation assay
Dr. Sonia Lain
University of Dundee, Dundee, United Kingdom
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Selectively targeting protein ubiquitination with an inhibitor of Nedd8 activating enzyme
Teresa Soucy, Ph.D.
Millennium Pharmaceuticals, Cambridge, MA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Targeting notch in cancer gamma secretase inhibitors
Christopher G. Winter, Ph.D.
Merck Research Laboratories, Boston, MA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4